127 results
Page 5 of 7
8-K
EX-99.1
tcs1c x8tiwzba66kl9
2 May 19
Other Events
7:10am
8-K/A
EX-99.1
sirgst 630xbdqwz6n
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
y60gz7 1nxfvux
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
d41lcbqj
18 Oct 18
Correspondence with SEC
12:00am
8-K
EX-99.1
d99hvjihrbztdwjg
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
6biwcv6
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
j11g3
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
nxgb0wa5oie09aa5mi
18 Jul 18
Other Events
5:01pm